Skip to content

Clinical Comparative Evaluation of the Use of Photodynamic Therapy in Conjunction With the Use of Vitamin D in Management Stage II Grade B Periodontitis Patients

Clinical Comparative Evaluation of the Use of Photodynamic Therapy in Conjunction With the Use of Vitamin D in Management Stage II Grade B Periodontitis Patients: A Randomized Controlled Clinical Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06700122
Enrollment
24
Registered
2024-11-21
Start date
2025-03-01
Completion date
2025-05-01
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Deficiency

Brief summary

Clinical Comparative Evaluation of the use of Photodynamic Therapy in conjunction with the use of Vitamin D in management Stage II Grade B Periodontitis Patients: A Randomized controlled clinical trial.

Detailed description

This randomized clinical trial evaluates the effect of Photodynamic therapy alone with SRP versus Photodynamic therapy with SRP and Vitamin D regarding Clinical evaluation 1. Clinical attachment loss (CAL) 2. Probing pocket depth (PPD) 3. Bleeding on probing (BOP)

Interventions

DIETARY_SUPPLEMENTnon-surgical periodontal therapy (SRP) and Photodynamic therapy (PDT) with systemic vitamin D

non-surgical periodontal therapy (SRP) and Photodynamic therapy (PDT) with systemic vitamin D

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Systemic healthy patients * Patients aged \> 25 years * Patients suffering from stage II periodontitis with grade B were included in this study, according to 2017 world workshop classification of periodontal disease. * Patients with interdental clinical attachment loss (CAL) of 3-4 mm with radiographic evidence of bone loss extending to coronal third of the root. * Radiographic bone loss (RBL) will be diagnosed using periapical parallel technique using 6 radiographic images for full mouth (3- radiographic images for maxillary arch and 3- radiographic images for mandibular arch) including anterior, canine region and posterior teeth at baseline for diagnosis. * No history of previous periodontal therapy. * No taken medications known to interfere healing or periodontal tissue health such as anticonvulsants, calcium channel blockers, or immunosuppressant drugs. * No previous periodontal surgery at involved sites. * Good oral hygiene and good compliance with the plaque control instructions following initial therapy. * Neither taken antibiotics within the last three months nor nonsteroidal anti-inflammatory drugs within the last three months * Absence of diseases or conditions that would interfere with wound healing such as diabetes mellitus or coagulation disorders

Exclusion criteria

Patients taking Vitamin D as a nutritional supplement were excluded from the study * Smoking habits * Pregnant and lactating mothers * Patients who have been received periodontal surgery in the study area during the last 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Clinical attachment level (CAL)Day 0 - Week 6CAL will be measured form cemento- enamel junction (CEJ) to the depth of the pocket using UNC periodontal probe. • It will be recorded at 6 sites per tooth, the recorded readings will be used to generate mean values at each time point.

Secondary

MeasureTime frameDescription
Probing Pocket Depth (PPD)Day 0 - Week 6PPD will be measured form free gingival margin (FGM) to the depth of the pocket using UNC periodontal probe.
Bleeding on probing (BOP)Day 0- Week 6Assessment after 30 seconds after gentle brushing of the sulcus with a periodontal probe, measurement quadrant

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORMarwa Helal

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026